Plain-English translation of NCT06735768 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a treatment called repetitive transcranial magnetic stimulation (rTMS) — a non-invasive technique that uses magnetic pulses applied to your scalp — to see if it can help prevent migraines. Right now, this treatment is not widely recommended for migraine prevention, so researchers want to gather solid evidence about whether it actually works in the short term.
While this treatment is considered safe, there is not enough reliable research showing whether it truly helps prevent migraines. This study aims to fill that gap and provide doctors with clear evidence to guide treatment decisions.
You likely qualify if…
You likely don't qualify if…
You would keep a migraine diary for 4 weeks before treatment begins, then receive three sessions of magnetic stimulation treatment spread over 10 days. After treatment, you would continue tracking your migraines in a diary for another 4 weeks. Half of participants will receive the actual treatment, and half will receive a placebo (sham treatment) to fairly compare results. Throughout the study, you cannot change any of your migraine medications.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
Austria